Suchergebnisse - "Histone-Lysine N-Methyltransferase"

PubPharm (1.041)

1

Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition

enthalten in: eLife | 2024

von Howard, G. | Wang, J. | Rose, K. | +17

UpdateOf: bioRxiv. 2024 Jan 10;:. - PMID 37546802

2

Identification of Novel NSD1 variations in four Pediatric cases with sotos Syndrome

enthalten in: BMC medical genomics | 2024

von Ren, Z. | Yue, L. | Hu, H. | +5

3

Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers

enthalten in: The journal of pathology. Clinical research | 2024

von van Toledo, D. | Bleijenberg, A. | Venema, A. | +8

4

Sotos syndrome with marked overgrowth in three Japanese patients with heterozygous likely pathogenic NSD1 variants : case reports with review of literature

enthalten in: Endocrine journal | 2024

von Masunaga, Y. | Ono, H. | Fujisawa, Y. | +3

5

NSD3 in Cancer : Unraveling Methyltransferase-Dependent and Isoform-Specific Functions

enthalten in: International journal of molecular sciences | 2024

von Nuñez, Y. | Vera, S. | Baeza, V. | +1

6

A novel nonsense variant in NSD1 gene in a female child with Sotos syndrome : A case report and literature review

enthalten in: Brain and behavior | 2023

von Liu, X. | Chen, C. | Wan, L. | +7

7

Neointima abating and endothelium preserving - An adventitia-localized nanoformulation to inhibit the epigenetic writer DOT1L

enthalten in: Biomaterials | 2023

von Shirasu, T. | Yodsanit, N. | Li, J. | +14

8

ASH2L, a COMPASS core subunit, is involved in the cell invasion and migration of triple-negative breast cancer cells through the epigenetic control of histone H3 lysine 4 methylation

enthalten in: Biochemical and biophysical research communications | 2023

von Batbayar, G. | Ishimura, A. | Lyu, H. | +6

9

Recent advances in EZH2-based dual inhibitors in the treatment of cancers

enthalten in: European journal of medicinal chemistry | 2023

von Yang, X. | Xu, L. | Yang, L.

10

NSD3 : Advances in cancer therapeutic potential and inhibitors research

enthalten in: European journal of medicinal chemistry | 2023

von Xiu, S. | Chi, X. | Jia, Z. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[105]